Ligand · LIA
LIA · (4-amino-2-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone
LIA, (4-amino-2-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone (C18 H21 F2 N5 O4 S, 441.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- LIA
- Formula
- C18 H21 F2 N5 O4 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LIA in 2 structures; the first of them:
- 2FVD · Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor · LIA A299 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
- 2FVD · Cyclin dependent kinase 2 (CDK2) with diaminopyrimidine inhibitor · LIA A299 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
Residues it binds most
ALA 2, ASP 2, GLN 2, LEU 2, LYS 2, PHE 2, VAL 2, ASN 2, GLU 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.